146 related articles for article (PubMed ID: 21052705)
1. 5-Lipoxygenase-activating protein (FLAP) inhibitor MK-0591 prevents aberrant alveolarization in newborn mice exposed to 85% oxygen in a dose- and time-dependent manner.
Park MS; Sohn MH; Kim KE; Park MS; Namgung R; Lee C
Lung; 2011 Feb; 189(1):43-50. PubMed ID: 21052705
[TBL] [Abstract][Full Text] [Related]
2. Leukotrienes are indicated as mediators of hyperoxia-inhibited alveolarization in newborn rats.
Boros V; Burghardt JS; Morgan CJ; Olson DM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L433-41. PubMed ID: 9124600
[TBL] [Abstract][Full Text] [Related]
3. Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes.
Manji JS; O'Kelly CJ; Leung WI; Olson DM
Am J Physiol Lung Cell Mol Physiol; 2001 Oct; 281(4):L799-806. PubMed ID: 11557583
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine kinase 1 deficiency confers protection against hyperoxia-induced bronchopulmonary dysplasia in a murine model: role of S1P signaling and Nox proteins.
Harijith A; Pendyala S; Reddy NM; Bai T; Usatyuk PV; Berdyshev E; Gorshkova I; Huang LS; Mohan V; Garzon S; Kanteti P; Reddy SP; Raj JU; Natarajan V
Am J Pathol; 2013 Oct; 183(4):1169-1182. PubMed ID: 23933064
[TBL] [Abstract][Full Text] [Related]
5. Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.
Velten M; Heyob KM; Rogers LK; Welty SE
J Appl Physiol (1985); 2010 May; 108(5):1347-56. PubMed ID: 20223995
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung.
Londhe VA; Sundar IK; Lopez B; Maisonet TM; Yu Y; Aghai ZH; Rahman I
Pediatr Res; 2011 May; 69(5 Pt 1):371-7. PubMed ID: 21270677
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
[TBL] [Abstract][Full Text] [Related]
8. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats.
Kunig AM; Balasubramaniam V; Markham NE; Morgan D; Montgomery G; Grover TR; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2005 Oct; 289(4):L529-35. PubMed ID: 15908474
[TBL] [Abstract][Full Text] [Related]
10. Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.
de Visser YP; Walther FJ; Laghmani el H; Steendijk P; Middeldorp M; van der Laarse A; Wagenaar GT
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(1):L56-67. PubMed ID: 21949154
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor treatment improves alveolarization in a newborn murine model of bronchopulmonary dysplasia.
Ohki Y; Mayuzumi H; Tokuyama K; Yoshizawa Y; Arakawa H; Mochizuki H; Morikawa A
Neonatology; 2009; 95(4):332-8. PubMed ID: 19122464
[TBL] [Abstract][Full Text] [Related]
12. Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen.
Park MS; Rieger-Fackeldey E; Schanbacher BL; Cook AC; Bauer JA; Rogers LK; Hansen TN; Welty SE; Smith CV
Pediatr Res; 2007 Dec; 62(6):652-7. PubMed ID: 17957151
[TBL] [Abstract][Full Text] [Related]
13. Impact of litter size on survival, growth and lung alveolarization of newborn mouse pups.
Feddersen S; Nardiello C; Selvakumar B; Vadász I; Herold S; Seeger W; Morty RE
Ann Anat; 2020 Nov; 232():151579. PubMed ID: 32688019
[TBL] [Abstract][Full Text] [Related]
14. Montelukast does not protect against hyperoxia-induced inhibition of alveolarization in newborn rats.
Jouvencel P; Fayon M; Choukroun ML; Carles D; Montaudon D; Dumas E; Begueret H; Marthan R
Pediatr Pulmonol; 2003 Jun; 35(6):446-51. PubMed ID: 12746941
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in long-term pulmonary outcomes of neonatal hyperoxia in mice.
Namba F; Ogawa R; Ito M; Watanabe T; Dennery PA; Tamura M
Exp Lung Res; 2016; 42(2):57-65. PubMed ID: 27070483
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia.
Ratner V; Slinko S; Utkina-Sosunova I; Starkov A; Polin RA; Ten VS
Neonatology; 2009; 95(4):299-305. PubMed ID: 19052476
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole Attenuates Pulmonary Aryl Hydrocarbon Receptor Activation and Potentiates Hyperoxia-Induced Developmental Lung Injury in Newborn Mice.
Shivanna B; Zhang S; Patel A; Jiang W; Wang L; Welty SE; Moorthy B
Toxicol Sci; 2015 Nov; 148(1):276-87. PubMed ID: 26272953
[TBL] [Abstract][Full Text] [Related]
18. Mechanical ventilation causes pulmonary mitochondrial dysfunction and delayed alveolarization in neonatal mice.
Ratner V; Sosunov SA; Niatsetskaya ZV; Utkina-Sosunova IV; Ten VS
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):943-50. PubMed ID: 23980609
[TBL] [Abstract][Full Text] [Related]
19. Capillary Changes Precede Disordered Alveolarization in a Mouse Model of Bronchopulmonary Dysplasia.
Appuhn SV; Siebert S; Myti D; Wrede C; Surate Solaligue DE; Pérez-Bravo D; Brandenberger C; Schipke J; Morty RE; Grothausmann R; Mühlfeld C
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):81-91. PubMed ID: 33784484
[TBL] [Abstract][Full Text] [Related]
20. Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn rats.
Méhats C; Franco-Montoya ML; Boucherat O; Lopez E; Schmitz T; Zana E; Evain-Brion D; Bourbon J; Delacourt C; Jarreau PH
PLoS One; 2008; 3(10):e3445. PubMed ID: 18941502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
